Research and development - Press Releases

Date	Title	Company
16-Apr-2021	GSK and Vir Biotechnology announce EMA review of dual-action monoclonal antibody VIR-7831 for the early treatment of COVID-19	GSK
16-Apr-2021	Merck to Discontinue Development of MK-7110 for COVID-19	Merck
15-Apr-2021	Top 10 Reasons to join SMi's 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference	SMi Group
15-Apr-2021	Oxitec Receives Landmark Biosafety Approval for New Fall Armyworm Control Solution	Oxitec
15-Apr-2021	Continued Improvements in Motor Milestones in Infants with Type 1 Spinal Muscular Atrophy After Two Years of Treatment with Evrysdi™	PTC Therapeutics, Inc.
15-Apr-2021	Boehringer Ingelheim adds blue internal teat sealant to its dairy mastitis portfolio	Boehringer Ingelheim
14-Apr-2021	Hope for poorer nations as a food staple, sodium-bicarbonate was found in a peer-reviewed study to significantly reduce Covid symptoms	Copper Clothing
14-Apr-2021	Seven million hours of patient data shows that Smith+Nephew’s wireless, wearable LEAF◊ Patient Monitoring System helps prevent hospital-acquired pressure injuries	Smith+Nephew
14-Apr-2021	Tagrisso approved in China in early lung cancer	AstraZeneca
09-Apr-2021	Occupational Toxicology and Placing Worker Safety at the Forefront to be discussed at HPAPi Conference	SMi Group
08-Apr-2021	Exclusive Speaker Interview with Achim Kless, Pain Genetics Lead from Eli Lilly & Company ahead of Pain Therapeutics	SMi Group
08-Apr-2021	Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble LAG-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer	Immutep
08-Apr-2021	Are They Remotely Relevant?	Owen Mumford Pharmaceutical Services
08-Apr-2021	AbbVie Submits Regulatory Applications for SKYRIZI® (risankizumab) in Psoriatic Arthritis to FDA and EMA	AbbVie
08-Apr-2021	New Roche data at 2021 AAN highlight impact and breadth of expanding neuroscience portfolio	Roche
08-Apr-2021	Novartis receives European and UK licence for Kesimpta® ▼ (ofatumumab), the first self-administered B-cell therapy for patients with relapsing forms of MS	Novartis
08-Apr-2021	Pfizer Announces Extension of Review of New Drug Application of Abrocitinib for The Treatment of Moderate to Severe Atopic Dermatitis	Pfizer
08-Apr-2021	Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months in the New England Journal of Medicine	Moderna
07-Apr-2021	FDA Keynote Speakers at SMi's 4th Annual Pharmaceutical Microbiology East Coast Virtual Conference in 3 weeks	SMi Group
07-Apr-2021	Fighting Cancer with Personalized Vaccines: OncoDNA and myNEO Join Forces to Unlock the Power of mRNA Therapeutics	OncoDNA